39 completed, 21 unknown, 7 recruiting, 3 active not recruiting. 74 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 74 | Completed 39, Unknown 21, Recruiting 7, Active not recruiting 3, Terminated 2, Not yet recruiting 1, Withdrawn 1 |
Follow Acute Myocardial Infarction: new trials by email Literature Review of Acute Myocardial Infarction trials Research Report on Acute Myocardial Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention Adenosine pre-medication, Standard care - ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon | Phase 4 | Recruiting | National Institute of Cardiovascular Diseases, Pakistan | 1148 | 2025-06-01 | 2026-04-22 |
| Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction Apixaban, Warfarin - Left Ventricular Thrombus, Acute Myocardial Infarction | Phase 4 | Recruiting | Karolinska Institutet | 212 | 2025-04-08 | 2025-07-01 |
| Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction Semaglutide - Diabetic Patients, Acute Myocardial Infarction | Phase 4 | Unknown | University of Sao Paulo General Hospital | 88 | 2024-09-01 | 2024-08-26 |
| Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE Influenza vaccine, Placebo - Acute Myocardial Infarction, Cardiovascular Diseases | Phase 4 | Recruiting | Region Örebro County | 90 | 2024-04-24 | 2026-04-07 |
| Ticagrelor De-escalation Strategy in AMI Patients De-escalation strategy, Conventional strategy - Acute Myocardial Infarction | Phase 4 | Recruiting | Dong-A University | 2312 | 2023-03-27 | 2025-10-01 |
| Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator Culprit lesion only PCI, Immediate multi-vessel PCI - Cardiogenic Shock, Acute Myocardial Infarction | Phase 4 | Recruiting | Samsung Medical Center | 560 | 2022-11-16 | 2024-11-06 |
| Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction alirocumab, conventional treatment - Acute Myocardial Infarction | Phase 4 | Recruiting | Shanghai Tong Ren Hospital | 160 | 2022-10-01 | 2026-01-27 |
| Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction Suxiao Jiuxin Pills, The placebo of Suxiao Jiuxin Pills - Acute Myocardial Infarction | Phase 4 | Not yet recruiting | Xiaolu Li | 116 | 2022-08-01 | 2022-07-20 |
| Optimal Dosage of Ticagrelor in Korean Patients With AMI Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg - Acute Myocardial Infarction, Ticagrelor | Phase 4 | Unknown | Dong-A University | 120 | 2022-01-01 | 2022-01-27 |
| The OPTIMA-5 Trail Recombinant Staphylokinase, normal saline - Acute Myocardial Infarction | Phase 4 | Completed | The First Affiliated Hospital with Nanjing Medical University | 200 | 2021-10-29 | 2023-01-13 |
| Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). De-prescribe beta blocker therapy - Coronary Artery Disease, Acute Myocardial Infarction | Phase 4 | Unknown | University of Saskatchewan | 200 | 2021-08-23 | 2022-11-09 |
| Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI Shexiang Tongxin Dropping Pills + routine treatment, routine treatment - Acute Myocardial Infarction | Phase 4 | Unknown | Peking University Third Hospital | 60 | 2021-08-01 | 2021-07-07 |
| Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention SGLT2 inhibitor, Control - Acute Myocardial Infarction, Heart Failure | Phase 4 | Recruiting | Samsung Medical Center | 200 | 2021-07-05 | 2025-06-26 |
| VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome Clopidogrel, Previous treatment - Acute Coronary Syndrome, Acute Myocardial Infarction | Phase 4 | Completed | Fundación EPIC | 637 | 2021-07-02 | 2026-09-22 |
| HOST - DAPT Duration According the Bleeding Risk Dual antiplatelet agent duration - Coronary Artery Disease, Acute Myocardial Infarction | Phase 4 | Active not recruiting | Seoul National University Hospital | 4900 | 2020-07-24 | 2025-07-23 |
| Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus Combination of antiplatelet drugs and anticoagulants for at least one month - Acute Myocardial Infarction, Left Ventricular Thrombus | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 120 | 2020-06-01 | 2020-02-11 |
| China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction Tongxinluo, Placebos - Acute Myocardial Infarction | Phase 4 | Unknown | China National Center for Cardiovascular Diseases | 3796 | 2019-05-23 | 2019-07-31 |
| Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction Metoprolol Succinate, Bisoprolol, Carvedilol - Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction (nSTEMI) | Phase 4 | Active not recruiting | Bispebjerg Hospital | 2760 | 2018-12-17 | 2025-06-10 |
| BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function Non-betablocker, Betablocker - Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction | Phase 4 | Active not recruiting | Oslo University Hospital | 2895 | 2018-10-01 | 2025-06-08 |
| Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction Cangrelor, Ticagrelor - Acute Myocardial Infarction, Cardiogenic Shock | Phase 4 | Completed | Faculty Hospital Kralovske Vinohrady | 605 | 2018-08-01 | 2025-04-02 |
Showing 20 of 74. Sign in to see all of them.
ST Elevation Myocardial Infarction (11) · Acute Coronary Syndrome (7) · Myocardial Infarction (7) · Non-ST Elevated Myocardial Infarction (5) · Coronary Artery Disease (4) · Diabetes Mellitus (3) · Shock, Cardiogenic (3) · Ventricular Remodeling (3) · Cardiovascular Diseases (2) · Heart Diseases (2) · Infarction (2) · Myocardial Ischemia (2) · No-Reflow Phenomenon (2) · Angina, Stable (1) · Angina, Unstable (1)
Cardiovascular Diseases (30) · Heart Diseases (29) · Vascular Diseases (29) · Myocardial Ischemia (27) · Pathological Conditions, Signs and Symptoms (26) · Pathologic Processes (22) · Ischemia (20) · Necrosis (20) · Infarction (18) · Myocardial Infarction (13) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Coronary Disease (4) · Endocrine System Diseases (4) · Metabolic Diseases (4)
Clopidogrel (7) · Ticagrelor (5) · Tirofiban (5) · Abciximab (3) · Atorvastatin (3) · Metoprolol (3) · 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (2) · Bisoprolol (2) · Colchicine (2) · Esomeprazole (2) · Famotidine (2) · Sodium Chloride (2) · Streptokinase (2) · reteplase (2) · Acetylcysteine (1)
Ospedale San Donato (3) · Samsung Medical Center (3) · University of Luebeck (3) · Dong-A University (2) · G.Gennimatas General Hospital (2) · Guangdong Provincial Hospital of Traditional Chinese Medicine (2) · Istanbul University (2) · Karolinska Institutet (2) · Ruttonjee Hospital (2) · The First Affiliated Hospital with Nanjing Medical University (2) · Yonsei University (2) · A.O. Ospedale Papa Giovanni XXIII (1) · Ajou University School of Medicine (1) · Bispebjerg Hospital (1) · Catharina Ziekenhuis Eindhoven (1)
China (12) · South Korea (12) · Italy (8) · Germany (6) · Sweden (4) · Czechia (3) · Japan (3) · Netherlands (3) · Poland (3) · Spain (3) · Turkey (Türkiye) (3) · United Kingdom (3) · Brazil (2) · Canada (2) · Denmark (2)
Berrin Umman, Prof. (2) · Fook Hong Ng, MBBS (2) · Giulio Guagliumi, MD (2) · Leonardo Bolognese, MD, FESC (2) · Sabahattin Umman, Prof. (2) · Ahmet K Bilge, M.D. (1) · Ake Ohlsson, M.D. PhD (1) · Anna Meta D Kristensen, MD (1) · Arif O Cimen, M.D. (1) · B. Rensing, MD, PhD (1) · Bertil Lindahl, MD PhD (1) · Bruno Scheller, MD (1)
PMID 36526898, PMID 40888716, PMID 41934630, PMID 10709908, PMID 12932593, PMID 15745837, PMID 15841305, PMID 1627164, PMID 16271642, PMID 16271643, PMID 16515501, PMID 16569536, PMID 16951276, PMID 17045887, PMID 17184583, PMID 17470709, PMID 17476008, PMID 17549308, PMID 17925603, PMID 18227478, PMID 18940887, PMID 19246588, PMID 19726437, PMID 19744615, PMID 19812399, PMID 19829124, PMID 20199815, PMID 20448126, PMID 20619238, PMID 20691839, PMID 20834185, PMID 20971744, PMID 21593301, PMID 21670242, PMID 21712524, PMID 22093203, PMID 22108447, PMID 22440498, PMID 22980307, PMID 23998121, PMID 24719126, PMID 24831770, PMID 25129664, PMID 25147029, PMID 25148231, PMID 25775052, PMID 25890582, PMID 26265659, PMID 26376600, PMID 26482376
2018 (3)